Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial
Authors
Keywords
-
Journal
JOURNAL OF INTERNAL MEDICINE
Volume 283, Issue 3, Pages 282-292
Publisher
Wiley
Online
2017-10-17
DOI
10.1111/joim.12702
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adherence to oral anticoagulant therapy in patients with atrial fibrillation
- (2017) Roberto Cangemi et al. THROMBOSIS AND HAEMOSTASIS
- Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
- (2017) Morten Lamberts et al. Journal of the American Heart Association
- How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?
- (2016) Gene R. Quinn et al. AMERICAN JOURNAL OF CARDIOLOGY
- Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin
- (2016) Keitaro Senoo et al. AMERICAN JOURNAL OF MEDICINE
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial
- (2016) Keitaro Senoo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes
- (2016) Benjamin A. Steinberg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
- (2016) Ziad Hijazi et al. LANCET
- Major Bleeding in Patients with Non-Valvular Atrial Fibrillation: Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores
- (2016) Marco Proietti et al. Scientific Reports
- Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
- (2014) Emily C. O’Brien et al. AMERICAN HEART JOURNAL
- Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
- (2014) Emily C. O'Brien et al. AMERICAN HEART JOURNAL
- 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
- (2014) Atul Verma et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. CIRCULATION
- Additional Events in the RE-LY Trial
- (2014) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies
- (2013) Neil S. Roskell et al. EUROPACE
- Bleeding Complications Associated with Warfarin Treatment in Ischemic Stroke Patients with Atrial Fibrillation: A Population-Based Cohort Study
- (2013) Raymond C.S. Seet et al. Journal of Stroke & Cerebrovascular Diseases
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Antithrombotic Therapy for Atrial Fibrillation
- (2012) John J. You et al. CHEST
- Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy
- (2012) Vanessa Roldán et al. CHEST
- Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study
- (2012) Leif Friberg et al. EUROPEAN HEART JOURNAL
- Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation
- (2012) Stavros Apostolakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review
- (2011) Dan Pugh et al. AGE AND AGEING
- Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
- (2011) John W. Eikelboom et al. CIRCULATION
- A New Risk Scheme to Predict Warfarin-Associated Hemorrhage
- (2011) Margaret C. Fang et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
- (2011) J. B. OLESEN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
- (2010) Ron Pisters et al. CHEST
- Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation
- (2010) Gregory Y.H. Lip et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Rationale and design of RE-LY: Randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran
- (2009) Michael D. Ezekowitz et al. AMERICAN HEART JOURNAL
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started